IP Education

The Patent Filing Journey

Two proven strategies for securing global patent protection. Understand every milestone, deadline, and decision before you begin.

158

PCT member countries

30

Months to decide where to file

3–7

Years to patent grant

20

Years of protection

1

Best Practice Path

Recommended for most startups

Provisional Application → PCT → National Phase

1Month 0Provisional2Month 12PCT Filing3Month 16–18Search Report4Month 30National Phase5Year 3–7Granted

Click any step to jump to its details

Step 1Month 0 — Priority date established

Provisional Patent Application

File a lower-formality application with the USPTO to lock in your priority date and gain 'Patent Pending' status. The provisional is never examined and automatically expires after 12 months, but it buys critical time to refine your invention, validate your market, and raise funding before committing to full prosecution costs.

Key facts

  • Establishes your priority date under first-inventor-to-file rules
  • Grants 'Patent Pending' status immediately
  • Starts the 12-month Paris Convention clock for international rights
  • Not examined — no patent issues from this filing alone
  • Does not reduce the 20-year patent term (which runs from the non-provisional filing)

File before any public disclosure, investor demo, or product launch. Many non-US countries have absolute novelty requirements — even a single public presentation before filing can destroy international patentability.

Step 2Month 12 — Must file before provisional expires

PCT International Application

File a single PCT application via WIPO to preserve your rights in up to 158 countries simultaneously. One application replaces what would otherwise be dozens of separate national filings. Choose an International Searching Authority (ISA) to conduct a prior art search — the result shapes your prosecution strategy in every country.

Key facts

  • Covers 158 member states with one filing
  • Choice of ISA: EPO (thorough), KIPO (cost-effective), or USPTO
  • Delays expensive national filings by 18 more months
  • Published publicly by WIPO at 18 months from priority date
  • Optional Chapter II examination for deeper pre-national-phase review

Strategic ISA choice matters. If Europe is your primary target, use the EPO as ISA — a favourable EPO search report carries significant weight into examination. KIPO (South Korea) is strong in electronics and software and is more cost-effective.

Step 3Month 16–18 — Critical decision point

International Search Report

The ISA issues a Written Opinion and a list of prior art references, giving you an early patentability assessment across all PCT member states. This is your most important strategic checkpoint: a strong report means confident national phase entry; a negative report is your signal to amend claims or rethink which countries to pursue.

Key facts

  • Prior art search across major global patent databases
  • Written Opinion gives preliminary patentability assessment
  • Converts automatically into the IPRP Chapter I report at month 30
  • File a Chapter II Demand by month 22 to argue claims before national entry
  • Favourable opinions can accelerate examination in many national offices

Review the Written Opinion with your patent attorney before committing to national phase countries. A negative opinion due to unexpected prior art may mean narrowing your strategy — far cheaper to do now than after filing in ten countries.

Step 4Month 30 — Hard deadline, no extensions

National Phase Entry

Choose which countries to enter. Each requires a separate national filing, local patent agent, and often translation. The 30-month deadline from your provisional is absolute in most jurisdictions — missing it means permanently losing rights in that country. US, EPO (covering 45+ European states), China, and Japan cover most of the world's economically significant patent markets.

Key facts

  • US, EPO, China, and Japan cover the majority of global patent value
  • EPO: one filing, then validate in individual European countries after grant
  • Translation required for China (Chinese), Japan (Japanese), Korea (Korean)
  • India, Canada, Australia: English-language prosecution accepted
  • Missing the 30-month deadline is generally unrecoverable

Build international prosecution costs into your Series A financial model. A typical 4-country portfolio requires significant runway — plan for both national phase entry and the prosecution period that follows.

Step 5Year 3–7 — Enforceable IP rights

Patent Granted

After examination and any required amendments in each jurisdiction, your patents issue. Each granted patent gives you enforceable rights to exclude competitors from making, using, or selling your invention in that country for up to 20 years from the original filing date. Rights can be licensed, sold, or used defensively against infringers.

Key facts

  • US: typically 3–4 years from provisional to grant
  • EPO: typically 4 years; validate in individual EU countries within 3 months of grant
  • China: typically 3.5–4 years
  • Japan: typically 3 years, with one of the highest grant rates globally
  • Annual renewal fees are due in each jurisdiction to keep patents in force

After EPO grant, validate in Germany, UK, France, and Netherlands at minimum — these are the four largest European patent markets. The post-grant validation window is just 3 months; missing it means losing protection in those countries permanently.

Why this is the recommended path for most startups

Capital efficient

A provisional is significantly less expensive than a full utility application. Defer the large spend until you have market validation or a funding round.

Aligns with fundraising

File provisional before your seed pitch, PCT during Series A, national phase around Series B when international expansion becomes concrete.

30 months to decide

You have 2.5 years from your provisional filing date to determine which markets actually matter before committing on a per-country basis.

2

US-First Path

Best when US market is primary

US Utility Application → PCT → National Phase

1Month 0US Utility2Month 12PCT Filing3Month 16–18Search Report4Month 30National Phase5Year 3–5Granted

Click any step to jump to its details

Step 1Month 0 — Examination begins immediately

US Utility Patent Application

File a full non-provisional utility patent application directly with the USPTO. Unlike a provisional, this enters the formal examination queue immediately. The application must contain finalised claims, a complete specification meeting enablement and written description requirements, an inventor oath, and drawings. Examination begins within 12–24 months.

Key facts

  • Enters USPTO examination queue immediately — no 12-month delay
  • All claims must be fully developed and finalised at filing
  • Average time to first office action: approximately 20 months
  • Track One prioritised examination available: first office action in ~1.3 months
  • 20-year term runs from this filing date

This path makes sense when your invention is fully developed, the US is your primary market, or a competitor is filing in the same space and speed to grant matters. Many funded startups choose it to compress US prosecution timelines.

Step 2Month 12 — From the US filing date

PCT International Application

Within 12 months of your US utility filing, file a PCT application claiming priority to it. The mechanics are identical to Path 1 from this point: one application covers 158 countries, an ISA conducts the prior art search, and you receive 18 more months before committing to national phase entry. The priority date is the US filing date.

Key facts

  • 12-month Paris Convention deadline runs from the US filing date
  • Same ISA choice and process as Path 1
  • US examination continues in parallel during the PCT phase
  • You may receive a US office action before national phase entry
  • A favourable US prosecution record can strengthen PCT prosecution

A key advantage: because US examination starts at month 0, you may receive — and respond to — a US office action before your 30-month national phase deadline. A positive US prosecution record can support faster allowance in other jurisdictions.

Step 3Month 16–18 — Same as Path 1

International Search Report

The ISA issues the same Written Opinion and prior art report as in Path 1. The strategic checkpoint is identical: review the report with your patent attorney, amend claims if needed, and decide which national phase countries to pursue. Your concurrent US prosecution may have already surfaced relevant prior art, making this review more informed.

Key facts

  • Same process as Path 1 — prior art search and Written Opinion
  • Compare ISR findings with any US office actions already received
  • File a Chapter II Demand by month 22 if claim amendments are needed
  • Favourable US prosecution history can inform and support national entry
  • Typical decision: enter 3–6 national jurisdictions
Step 4Month 30 — Same hard deadline

National Phase Entry

National phase entry follows the same process as Path 1. The difference: your US application may already be at an advanced prosecution stage — potentially with allowed claims. A US allowance before national phase entry strengthens your negotiating position and can accelerate examination in countries that follow US prosecution closely.

Key facts

  • Same country options, costs, and deadlines as Path 1
  • US application runs concurrently — may already have allowed claims
  • Allowed US claims can accelerate prosecution in Japan, Australia, and Canada
  • EPO and China conduct independent examination regardless
  • Same 30-month absolute deadline from US filing date

Japan, Australia, and Canada often follow US prosecution closely. An issued US patent can meaningfully accelerate grant in those jurisdictions, reducing overall international prosecution time and cost.

Step 5Year 3–5 — Potentially faster US grant

Patent Granted

The key difference from Path 1: your US patent may grant 12–24 months earlier because prosecution started at month 0 rather than month 12. International grants follow the same timeline as Path 1 in each jurisdiction. An earlier US grant can be material if licensing discussions, competitor activity, or investor exit timing are considerations.

Key facts

  • US grant potentially 12–24 months earlier than Path 1
  • Same international grant timelines as Path 1 in each jurisdiction
  • Earlier US grant supports licensing and enforcement earlier
  • USPTO Track One can compress US grant to under 6 months from filing
  • US grant can be leveraged in parallel international prosecution

When to choose the US-First path

Fully developed invention

All embodiments, best mode, and claims are clearly defined. No 12-month refinement window needed — filing a provisional first would only add steps.

Speed is critical

A known competitor is filing in the same space, a licensing deal is pending, or investors need a granted patent before a funding round closes.

Well-funded company

Series A or B funding is in hand. The higher upfront cost is manageable, and the total cost through US grant is actually lower than filing a provisional first.

Side-by-Side Comparison

Both paths lead to the same destination. The difference is flexibility, upfront commitment, and speed to US grant.

FactorPath 1 — Provisional → PCTPath 2 — US Utility → PCT
Upfront filing costLower — defer to PCT phaseHigher — all costs upfront
Total cost through US grantHigher (two separate filings)Lower (one filing)
US examination startMonth 12 (delayed)Month 0 (immediate)
Time to US patent grant3–4 years from provisional2–3 years from filing
Claim flexibilityHigh — 12 months to finaliseLower — must be final at filing
International rights window30 months from provisional30 months from US filing
Countries covered (PCT)158 countries158 countries
Ideal stagePre-seed / SeedSeries A / B
Best whenInvention still evolving, budget constrained, need runway to validateInvention complete, competitor threat, fast US grant needed

Which Path Is Right for You?

If you answer yes to most of the points in a column, that path is likely the better fit.

1

Choose the Best Practice Path if...

  • Your invention is still being refined or developed
  • You are pre-seed or seed-stage with budget constraints
  • You need 'Patent Pending' status quickly but can't commit to full prosecution costs now
  • You haven't decided which international markets matter yet
  • You are filing before an investor pitch or product launch
  • You want maximum runway before committing to national filings
2

Choose the US-First Path if...

  • Your invention is fully developed with all embodiments defined
  • You have Series A or B funding and the budget is available
  • A known competitor is filing in the same technology space
  • A licensing deal or acquisition discussion is already in progress
  • The US is your primary or only near-term commercial market
  • You want to use USPTO Track One for accelerated US examination

Common mistakes to avoid — on either path

Filing a thin provisional that doesn't fully support future claims
Missing the 12-month deadline to file PCT after your first application
Disclosing publicly before any application is on file
Ignoring the Written Opinion from the International Search Report
Underestimating national phase translation and local attorney fees
Missing the 3-month EPO validation window after grant
Overlooking India — large English-language market with lower fees
Forgetting annual renewal fees across each national jurisdiction

Most Common National Phase Destinations

For tech startups — representing over 90% of the world's economically significant patent markets

🇺🇸

United States

English

Tier 1
🇪🇺

European Patent Office

EN / FR / DE

Tier 1
🇨🇳

China

Chinese translation

Tier 1
🇯🇵

Japan

Japanese translation

Tier 1
🇰🇷

South Korea

Korean translation

Tier 2
🇮🇳

India

English

Tier 2
🇨🇦

Canada

English

Tier 2
🇦🇺

Australia

English

Tier 2

Ready to start your patent journey?

Patenti.AI guides you through every step — from capturing your invention disclosure to drafting a patent-ready application. Both paths, fully supported.